See the DrugPatentWatch profile for yervoy

Yervoy, a cancer treatment drug used for the treatment of melanoma, can impact out-of-pocket costs for patients, depending on their insurance coverage.

Generally, the cost of Yervoy can be quite high, with a course of treatment potentially costing upwards of $100,000 or more. However, the specific out-of-pocket costs for patients will depend on several factors, including their insurance plan's coverage for the drug, their deductible, and any co-pays or coinsurance requirements.

Some insurance plans may cover Yervoy completely, meaning that patients would not have to pay anything out of pocket for the drug. However, other plans may require patients to pay a percentage of the cost, known as coinsurance, or a fixed amount for each prescription, known as a co-pay. Additionally, some plans may require patients to meet a deductible before coverage kicks in, which could result in higher out-of-pocket costs upfront.

It's worth noting that the cost of Yervoy may be covered under medical benefits rather than prescription drug benefits, which could impact out-of-pocket costs. Additionally, some patients may be eligible for financial assistance programs offered by the drug manufacturer or third-party organizations, which could help offset the cost of the drug.

In summary, the impact of Yervoy coverage on out-of-pocket costs for patients will depend on several factors, including their insurance plan's coverage, deductibles, co-pays, and coinsurance requirements. Patients are encouraged to speak with their insurance provider and healthcare team to better understand their specific coverage and out-of-pocket costs for Yervoy.

Sources:

1. [DrugPatentWatch.com](https://www.drugpatentwatch.com/drugs/yervoy)
2. [Mayo Clinic](https://www.mayoclinic.org/diseases-conditions/melanoma/diagnosis-treatment/drc-20374883)
3. [American Cancer Society](https://www.cancer.org/cancer/melanoma-skin-cancer/treating/immunotherapy-and-targeted-therapy-for-melanoma.html)